134 related articles for article (PubMed ID: 7064015)
1. IgD myeloma. A report of 4 new cases.
De Waal A; Potgieter GM; Visser AE; Heyns AD
S Afr Med J; 1982 Mar; 61(11):407-10. PubMed ID: 7064015
[TBL] [Abstract][Full Text] [Related]
2. IgD multiple myeloma. A case report.
Dauth J; Politzer WM; Christodoulou AG; De Coning JP; Robertson T; Du Plessis DP
S Afr Med J; 1985 Dec; 68(13):965-6. PubMed ID: 4081936
[TBL] [Abstract][Full Text] [Related]
3. Immunodiagnosis of IgD multiple myeloma. A report of 17 cases.
Chernokhvostova EV; Batalova TN; German GP; Andreyeva NE
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(4):539-52. PubMed ID: 6170548
[TBL] [Abstract][Full Text] [Related]
4. [Multiple myeloma with D immunoglobulin].
Benchekroun L; Ouzzif Z; Bouabdillah M; Jaouhar N; Aoufir F; Aoufi F; Chabraoui L
Ann Biol Clin (Paris); 2011; 69(5):581-7. PubMed ID: 22008139
[TBL] [Abstract][Full Text] [Related]
5. Immunochemical analysis of IgD-lambda paraprotein in myeloma.
Tichý M; Hrncír Z; Pola V; Mazák J
Neoplasma; 1974; 21(4):487-91. PubMed ID: 4215041
[No Abstract] [Full Text] [Related]
6. [Bence Jones protein (lambda) myeloma with non-secretory IgD: report of a case].
Kaneto Y; Sumiyoshi T; Iishi Y; Iguchi K; Kosaka M
Rinsho Ketsueki; 1984 May; 25(5):673-8. PubMed ID: 6433075
[No Abstract] [Full Text] [Related]
7. Clinical manifestations of multiple myeloma: relation to class and type M component.
Pruzanski W
Can Med Assoc J; 1976 May; 114(10):896-7. PubMed ID: 817790
[TBL] [Abstract][Full Text] [Related]
8. IgD plasma cell neoplasia: clinical manifestations and characteristic features.
Pruzanski W; Rother I
Can Med Assoc J; 1970 May; 102(10):1061-5. PubMed ID: 5000054
[TBL] [Abstract][Full Text] [Related]
9. IgD multiple myeloma. Review of 133 cases.
Jancelewicz Z; Takatsuki K; Sugai S; Pruzanski W
Arch Intern Med; 1975 Jan; 135(1):87-93. PubMed ID: 1111472
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin D multiple myeloma.
Lin TL; Shih LY; Dunn P; Wang PN; Wu JH; Kao MC
Chang Gung Med J; 2000 Aug; 23(8):451-7. PubMed ID: 11039246
[TBL] [Abstract][Full Text] [Related]
11. IgD myeloma: clinical, biological and laboratory features.
Sinclair D
Clin Lab; 2002; 48(11-12):617-22. PubMed ID: 12465746
[TBL] [Abstract][Full Text] [Related]
12. IgD myeloma protein with "unreactive" light chain determinants.
Cejka J; Kithier K
Clin Chem; 1979 Aug; 25(8):1495-8. PubMed ID: 88283
[TBL] [Abstract][Full Text] [Related]
13. Anomalous urinary proteins in patients with serum M-components.
Pruzanski W; Ogryzlo MA
Can Med Assoc J; 1971 Apr; 104(7):581-8. PubMed ID: 4994475
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal IgD. A comparative study of 60 sera with IgD "M" component.
Fine JM; Rivat C; Lambin P; Ropartz C
Biomedicine; 1974 Mar; 21(3):119-25. PubMed ID: 4429767
[No Abstract] [Full Text] [Related]
15. IgD multiple myeloma with thoracic spine compression due to epidural extra-osseous tumour spread.
Lolin YI; Lam CW; Lo WH; Au KL; Masarei JR
J Clin Pathol; 1994 Jul; 47(7):669-71. PubMed ID: 8089229
[TBL] [Abstract][Full Text] [Related]
16. IgD myeloma: a potential missed diagnosis.
Sinclair D; Cranfield T
Ann Clin Biochem; 2001 Sep; 38(Pt 5):564-5. PubMed ID: 11587138
[TBL] [Abstract][Full Text] [Related]
17. IgD myeloma with myelofibrosis and amyloidosis.
Udoji WC; Pemmaraju S
Arch Pathol Lab Med; 1977 Jan; 101(1):10-3. PubMed ID: 401635
[TBL] [Abstract][Full Text] [Related]
18. Alternating appearance of IgD and IgG myeloma protein during treatment.
Oxelius VA
Scand J Haematol; 1971; 8(6):439-45. PubMed ID: 5160304
[No Abstract] [Full Text] [Related]
19. [The successful use of natural alpha-interferon single therapy in multiple myeloma of IgD (lambda)-type].
Suzuki A; Iwase O; Ohkubo T; Nakano M; Toyama K
Rinsho Ketsueki; 1991 Jan; 32(1):47-51. PubMed ID: 1902271
[TBL] [Abstract][Full Text] [Related]
20. Technical aspects of the detection and characterization of immunoglobulin dyscrasis.
Conway BP
Health Lab Sci; 1972 Jul; 9(3):185-96. PubMed ID: 4625660
[No Abstract] [Full Text] [Related]
[Next] [New Search]
